ArticleBlood advances2025

LNS-8801 as a therapeutic agent for aggressive lymphomas: ROS-induced cytotoxicity and synergy with existing therapies.

Yang Li et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.